Pharmacology and Therapeutics of Asthma and COPD

Inbunden, Engelska, 2017

Del 237 i serien Handbook of Experimental Pharmacology

3 100 kr

Beställningsvara. Skickas inom 10-15 vardagar. Fri frakt över 249 kr.

Beskrivning

The present volume is supposed to be a major reference resource for chest physicians and those involved in the development of novel pharmaceutical entities for these diseases. Internationally recognized authorities review the most important new information on the advances in our understanding of the pathogenesis and treatment of these diseases, including the substantial advances in the topical delivery of inhaled medicines. Each chapter is extensively referenced, generously illustrated with clear diagrams and photographs, and represents a state-of-the-art review of this important area of respiratory medicine.

Produktinformation

Utgivningsdatum:2017-02-13
Mått:155 x 235 x 21 mm
Vikt:665 g
Format:Inbunden
Språk:Engelska
Serie:Handbook of Experimental Pharmacology
Antal sidor:285
Upplaga:17001
Förlag:Springer International Publishing AG
ISBN:9783319521732

Utforska kategorier

Recensioner i media

“This is an excellent guide to help readers understand the thinking behind management choices in asthma and chronic obstructive pulmonary disease. … This book, written by a respected group of international authors, will provide a valuable reference for both primary and secondary care clinicians as well as allied health professionals and students who are looking for succinct, up-to-date information to help them treat patients with asthma or chronic obstructive pulmonary disease.” (J. K. Quint, British Journal of Hospital Medicine, Vol. 78 (5), May, 2017)

Innehållsförteckning

Pathogenesis of bronchial asthma and chronic obstructive pulmonary disease – common diseases with unmet needs.- Beta 2 agonists.- Muscarinic receptor antagonists.- Xanthines and Phosphodiesterase inhibitors.- Glucocorticosteroids.- Fixed dose combination inhalers.- Anti-IgE and biologic approaches for the treatment of asthma.- Leukotriene receptor antagonists and anti-allergy drugs.- Novel anti-inflammatory drugs.- Bifunctional drugs for the treatment of respiratory diseases.- Drugs affecting TRP channels.- Evaluation of new drugs for asthma and COPD: endpoints, biomarkers and clinical trial design.- Drug delivery devices for inhaled medicines.